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Although sexual functioning is an important facet of a living donor’s quality of life, it has not received an extensive evaluation
in this population. Using data from the Adult-to-Adult Living Donor Liver Transplantation Cohort Study, we examined donor
sexual functioning across the donation process from the predonation evaluation to 3 months and 1 year after donation.
Donors (n5 208) and a comparison group of nondonors (n5155) completed self-reported surveys with specific questions
on sexual desire, satisfaction, orgasm, and (for men) erectile function. Across the 3 time points, donor sexual functioning
was lower at the evaluation phase and 3 months after donation versus 1 year after donation. In the early recovery period,
abdominal pain was associated with difficulty reaching orgasm [odds ratio (OR), 3.98; 95% confidence interval (CI), 1.30-
12.16], concerns over appearance were associated with lower sexual desire (OR, 4.14; 95% CI, 1.02-16.79), and not feeling
back to normal was associated with dissatisfaction with sexual life (OR, 3.58; 95% CI, 1.43-8.99). Efforts to educate donors
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Living liver donors offer a portion of their own healthy
liver to save the life of another. Because donors make
a personal sacrifice to enhance the welfare of another,
efforts to prevent adverse health and quality-of-life
outcomes are essential. Much has been written about
the health-related quality of life (HRQOL) of donors,
their typically high levels of functioning before and
after donation, and their often quick physical recov-
ery.1-7 However, to date, there has been little exami-
nation of donor sexual functioning through the
donation process. A single-center study that included
1 question about whether donation had affected sex-
ual function or intimacy showed that nearly 50% of
donors reported worsened sexual functioning 1 week
to 1 month after donation, but most reported a return
to the baseline at 3 months after donation.2 A retro-
spective cross-sectional survey of liver donors’ HRQOL
that asked a single question about sexual functioning
found that those who reported a lower perception of
body image and cosmesis reported significantly
greater interference in their sex lives.8
Thus, with the intent to identify the scope and
extent of donor sexual concerns, we examined donor
sexual functioning before and after donation with the
multisite Adult-to-Adult Living Donor Liver Trans-
plantation Cohort Study (A2ALL). The purpose of our
study was (1) to describe the sexual functioning of
liver donors, including changes through the first year
after donation, and (2) to evaluate whether and to
what extent donation-related factors (eg, self-reported
recovery from the surgery, physical symptoms, pain,
appearance, and health concerns) were associated
with poorer sexual functioning.
PATIENTS AND METHODS
Study Design and Cohort Definitions
The A2ALL consortium consisted of 9 North American
transplant centers with data collected on potential liv-
ing liver donors and their recipients. Patients were
recruited from 2004 to 2009 with follow-up through
August 2010. All individuals evaluated for living liver
donation at these centers were asked to complete
HRQOL surveys, including sexual functioning ques-
tions. Potential donors could enter the study during
the donor evaluation process or at a later time point if
they had already donated. Surveys were administered
at evaluation and at 3 months and 1 year after dona-
tion and at evaluation and 3 months and 12 months
after evaluation for those who did not donate (nondo-
nors). For participants who enrolled after donation,
the surveys were administered according to the proto-
col visit schedule and were started with the visit win-
dow after donation. Clinical information, including
data on donor hospitalizations, complications, and
recipient outcomes, was collected from the medical
record, which was supplemented with data from the
Scientific Registry of Transplant Recipients.
Of the 971 consenting potential donors, 170 were
excluded because they enrolled in the A2ALL protocol
more than 2 years after donation or evaluation and
were beyond the time points of interest (Fig. 1). An addi-
tional 142 nondonating candidates were excluded
because of factors that may have made their reports of
sexual functioning less comparable to those of actual
donors; for example, those who declined to donate or
were rejected as donors for medical or psychosocial
contraindications were excluded. Of the remaining 659
who were eligible to be donors, 293 were donors, and
366 were nondonors. Nondonors did not donate mostly
because of recipient (eg, the recipient received a
deceased donation) or anatomical reasons. Surveys
were completed at the evaluation phase before it was
known that the nondonors would not donate. We chose
nondonors to be the control group because they would
be similar to the donor group with respect to health and
psychological functioning. Donors are healthier than
the general population of age-matched individuals
because they are specifically screened to not have med-
ical or psychosocial issues. Thus, a comparable group
would be eligible donors who eventually did not donate
mostly because of recipient reasons and not because
they had medical or psychological issues that pre-
vented them from donating. Of those, 208 donors (71%)
and 155 nondonors (42%) completed at least 1 sexual
functioning questionnaire and were included in the
analyses. There were no statistical differences between
responders and nonresponders in demographics or for
donors in postdonation factors (complications, hospi-
talizations, or recipient death/retransplantation).
Human Subjects Protection
A2ALL, which collected the data in the present report,
was approved by the institutional review boards and
privacy boards of the University of Michigan Data
Coordinating Center and each of the 9 participating
transplant centers. All participants provided written
informed consent.
Instruments and Measures (see Table 1)
Surveys were self-administered. The questions were
preceded by a statement that responses would be
kept confidential and not revealed to the transplant
team.
Sexual Functioning Questions
Of the component parts of sexual activity, desire,
erectile function (for men), and overall sexual
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satisfaction are considered some of the most important
dimensions of sexual functioning.9 Self-report surveys
are considered one of the most valid ways to assess sex-
ual functioning.9 Specific questions addressing each of
these areas for men and women were developed and
validated by expert sexuality researchers,9,10,13 and
they have been used in studies of sexual functioning
after general and urological/gynecological surgery.14-16
Donors were surveyed with 4 of these questions cover-
ing core sexual functioning areas: 3 assessed both men
and women (orgasmic function, desire, and overall sat-
isfaction), and a fourth item assessed men (erectile
function). The time frame for each item was the prior
month. We dichotomized responses on each sexual
functioning item into those endorsing the item half the
time or less (poorer sexual functioning) versus those
endorsing better sexual functioning. For questions
about erectile and orgasmic function, responses of no
sexual activity (either stimulation or intercourse) were
included in the poorer functioning group. The question
on satisfaction with sex life was dichotomized as satis-
fied versus neutral or dissatisfied.
Postdonation Covariates: Symptoms and
Concerns
Postdonation surveys included items on recovery (fully
recovered versus not), being physically back to normal
(yes versus no), pain (any versus none), pain interfer-
ence with functioning (any versus never), bowel symp-
toms interfering with functioning (any versus never),
and physical appearance (same/better versus worse).
Symptoms of depression were elicited with 2 screen-
ing questions from the Mini-International Neuro-
psychiatric Interview12 on the 2 cardinal symptoms of
depression required for the clinical diagnosis (present
or not; see Table 1).
Several validated instruments assessing donation-
specific concerns (eg, relationships, satisfaction with
donation, and health concerns related to donation)11
have been used extensively in bone marrow,17-20 kid-
ney,21,22 and liver23,24 donation research. From these
instruments, we chose health concerns related to the
donation experience as the most relevant to sexual func-
tioning. Four individual items representing the donation-
related health concerns domain were assessed: the
future negative effects of donation on health (agree ver-
sus disagree), worries about current health (any worries
versus none), frequency of worries (often to sometimes
versus almost never), and worries about never feeling
physically 100% again (agree versus disagree).
Demographic and Donor Medical Outcomes
Basic demographics, the relationship with the actual/
intended recipient, medical comorbidities, smoking
Figure 1. Study flow diagram showing the number of donors who consented and were excluded from the analysis because of ineligi-
bility and the number of subjects with (analyzed) and without (not analyzed) sexual functioning survey responses in the first year after
donation.
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TABLE 1. Donor Survey Questions and Sources
Content Area Specific Questions Source Scoring
Sexual Functioning Questions
Desire or interest Over the past month, how often did you feel
sexual desire or interest?
 Almost always or always
 Most times (more than half the time)
 Sometimes (about half the time)
 A few times (less than half the time)
 Almost never or never
For female questions,
see Rosen et al.9
(2000)
For male questions,
see Rosen et al.10
(1997)
For questions on
desire, orgasm/
ejaculate and erec-
tion:
 Poorer functio-
ning5 sometimes,
a few times,
almost never/
never
 For satisfaction
question:
 Poorer functio-
ning5about
equally satisfied/
dissatisfied, mod-
erately dissatis-
fied, very
dissatisfied
Orgasm/ejaculate Over the past month, when you had sexual
stimulation or intercourse, how often did you
reach orgasm (climax)/ejaculate?
 Almost always or always
 Most times (more than half the time)
 Sometimes (about half the time)
 A few times (less than half the time)
 Almost never or never
 No sexual stimulation/intercourse
Satisfaction with
sexual life
Over the past month, how satisfied have you
been with your overall sexual life?
 Very satisfied
 Moderately satisfied
 About equally satisfied and dissatisfied
 Moderately dissatisfied
 Very dissatisfied
Ability to get an
erection (for men
only)
Over the past month, how often were you
able to get an erection during sexual activity?
 Almost always or always
 Most times (more than half the time)
 Sometimes (about half the time)
 A few times (less than half the time)
 Almost never or never
 No sexual activity
Postdonation Covariates: Donation-Specific Worries
Content Area Specific Questions Source
Worries about
health related to
donation
How often do you worry about the physical
effects on you of having donated a part of
your liver?
 Often
 Sometimes
 Almost never
See Simmons et al.11
(1987)
Would you say you are. . .
 Very worried about your own health now
 Somewhat worried
 A little worried
 Not at all worried about your own health
now
Sometimes I worry that the liver donation will
have negative effects on my health in the
future.
 Strongly agree
 Agree
 Disagree
 Strongly disagree
Since my liver donation, I worry that I will
never feel physically 100% well again.
 Strongly agree
 Agree
 Disagree
 Strongly disagree
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TABLE 1. Continued
Content Area Specific Questions Source Scoring
Physical Appearance, Symptoms, and Recovery
Bodily appearance Compared to before donation, my general or
overall physical appearance now is:
 Much worse
 Worse
 The same
 Better
 Much better
Survey items created
by A2ALL investiga-
tors to capture these
donation-specific
issues
Abdominal pain
and bowel
symptoms
Abdominal pain interferes with my daily
life Never Rarely
Sometimes Often Always
The amount of abdominal pain I have today
is
 None
 Mild
 Moderate
 Severe
 Very severe
Extent of recovery My bowel symptoms interfere with daily life
 Never
 Rarely
 Sometimes
 Often
 Always
Do you feel completely recovered now?
 Yes
 No
If no, how would you rate your percentage of
recovery now?
 81%-100%
 61%-80%
 41%-60%
 21%-40%
 0%-20%
Compared to what I expected, my recovery
has been:
 Much slower
 Slower
 As expected
 Faster
 Much faster
Physically, do you feel back to normal?
 Yes
 No
Depression symptoms
In the past 2 weeks, have you been much
less interested in most things or much less
able to enjoy the things you used to enjoy
most of the time?
 Yes
 No
See Sheehan et al.12
(1998)
Have you been consistently depressed or
down, most of the day, nearly every day, for
the past 2 weeks?
 Yes
 No
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status, and body mass index (BMI) were obtained
from medical records. Marital/relationship status and
educational level were asked by survey. For donors,
data on the liver lobe donated, medical complications
(number and Clavien grade), number of rehospitaliza-
tions, and recipient status at follow-up (alive,
deceased, or retransplanted) were collected from med-
ical record reviews. Donors were asked about current
pain medication usage. After donation, women were
asked whether they were pregnant or attempting to
become pregnant.
Data Considerations
A2ALL represents 79% of living donors from the corre-
sponding era. Those who did and did not enroll in
A2ALL were similar in age (37.4610.1 and
36.2610.3 years, respectively; P50.43), and similar
percentages were enrolled by sex (80% among females
and 77% among males; P50.53). However, white,
native, and multiracial donors were more likely to
enroll (82%) than blacks (63% of 16 donors) or Asians
(36% of 14 donors; P<0.001). Of the 208 donors ana-
lyzed, 122 completed the questionnaire at the evalua-
tion, 105 completed it 3 months after donation, and
107 completed it 1 year after donation. Eighty-two
donors responded at the evaluation and at least 1
postdonation time point of interest (3 months and/or
1 year after donation). Of the 155 nondonors, 134
responded at the evaluation, 21 responded 3 months
after the evaluation, and 13 responded 1 year after
the evaluation. Only 13 nondonors responded at mul-
tiple time points, and only 12 responded at the evalu-
ation and 1 postevaluation time point; thus, there
were too few nondonors to consider for the longitudi-
nal analyses. Among eligible donors and nondonors,
no significant differences existed between those ana-
lyzed or excluded in the demographic variables in
Table 2.
To maximize response rates, surveys were adminis-
tered in several formats: tablet computers (n5341),
paper forms (n5157), and a web-based format
(n54). No statistical differences existed between the
tablet and paper formats for any of the sexual func-
tioning questions.
Statistical Analysis
Characteristics of donors and nondonors were com-
pared with t tests for continuous variables and with
chi-square or Fisher’s exact tests for categorical varia-
bles. Graphs of the proportion indicating poorer sex-
ual function included standard error (SE) bars based
on the binomial distribution.
Potential predictors of poor sexual function were
first evaluated at each time point for each question.
Both donors and nondonors were included in models
at evaluation; only donors were included in postdona-
tion models. Covariates considered included donation
age, sex, race, ethnicity, relationship to recipient,
marital status, education, BMI, smoking history, his-
tory and current symptoms of depression, and
TABLE 2. Characteristics of Living Liver Donors and Nondonors at the Predonation Evaluation Stage
Actual Donors (n5208),
% (n) or Mean (SD)
Nondonors (n5155),
% (n) or Mean (SD) P Value*
Age at evaluation, years 37.9 (10.2) 37.4 (10.6) 0.612
18-29 years 27% (56) 30% (47)
30-39 years 31% (64) 24% (37)
40-49 years 27% (56) 35% (54)
50 years 15% (32) 11% (17)
Male 45% (94) 52% (80) 0.23
Hispanic 12% (24) 17% (26) 0.15
White 94% (195) 85% (131) 0.004
BMI at evaluation (kg/m2) 26.4 (4.1) 27.3 (5.3) 0.09
High school education or less† 23% (48) 22% (34) 0.85
Current or previous smoker 24% (49) 30% (46) 0.19
History of depression 8% (16) 8% (13) 0.81
Dyslipidemia 7% (14) 7% (11) 0.89
Coronary artery disease 0% (0) 1% (1) 0.43
Pulmonary disease 3% (6) 2% (3) 0.74
Diabetes <1% (1) 0% (0) >0.99
Hypertension 3% (7) 1% (2) 0.31
Relationship to recipient 0.91
Biological 65% (136) 66% (103)
Nonbiological, spouse 6% (12) 6% (10)
Other nonbiological 29% (60) 27% (42)
Married/long-term partner 37% (77) 49% (76) 0.02
*Chi-square Fisher’s exact, or t test.
†Missing in 10% of subjects.
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dyslipidemia. Diabetes, pulmonary disease, heart dis-
ease, and hypertension were uncommon and not
tested. Covariates considered for the postdonation
models additionally included the lobe donated and
measures from the given survey or earlier: number of
hospitalizations, number of complications (overall and
severity), medications for pain, recipient death or
retransplant, depressive symptoms, abdominal pain,
bowel symptoms, concerns about appearance, and
donation-related worries. Variable selection used the
method of best subsets,25 with sex retained even if
not significant. Results are presented as odds ratios
(ORs) with 95% confidence intervals (CIs).
To investigate changes in the probability of poorer
sexual function following donation, repeated meas-
ures logistic models were fit to the subgroup with the
evaluation and at least 1 postdonation survey; a com-
pound symmetry covariance structure was used. This
method yields unbiased inference even if subjects
have missing surveys at some time points under the
assumption that the missing data mechanism is igno-
rable. The covariates considered previously were
tested with adjustments for sex and time point. The
interactions between sex and time were tested but
were not found to be significant. Results are pre-
sented as predicted probabilities of poorer sexual
function, with P values given for tests of sex differen-
ces and pairwise time point differences. Predonation
sexual function was also tested as a predictor of post-
donation function with a similar model that included
predonation function as a covariate.
RESULTS
Descriptive Results
Donors and nondonors were similar in most baseline
demographic characteristics. They were predomi-
nantly white, were evenly divided between men and
women, and were on average 37.7 years old (Table 2).
Only 0% to 3% had medical comorbidities of diabetes,
pulmonary disease, heart disease, or hypertension.
Dyslipidemia (7% of both groups) was not significantly
associated with sexual functioning. The majority
intended to donate to a biological relative, and a small
percentage intended to donate to a spouse. Compared
to nondonors, donors were more likely to be white
and unmarried. Three female donors reported
attempting to get pregnant in the year after donation.
Among donors, most donated the right lobe of their
liver, and after the initial donation hospitalization,
most were not hospitalized again during the first year
(Table 3). Most complications occurred within the first
3 months, with 36% experiencing at least 1 complica-
tion within the first year. The highest grade complica-
tion was Clavien grade 2 (21% in the first year).26 By
1 year, 5% of the living liver donor recipients had
died, and another 5% were retransplanted. Few
donors reported symptoms of depression or concerns
about appearance. However, bowel symptoms and
pain were common. At 1 year, 40% reported bowel
symptoms, and 46% reported abdominal pain that
interfered with everyday life. Nevertheless, at 1 year,
75% felt back to normal. Most felt that their recovery
pace was as expected or faster. Although few worried
that they would never feel physically 100% again, at 3
months, 35% were at least a little worried about their
health, and 42% worried about the physical effects of
donation.
What Are the Prevalence and Specific Types of
Sexual Concerns/Problems Both Before and
After Liver Donation?
Figure 2A-D shows the percentage of responses indi-
cating poorer sexual functioning on each survey item
at evaluation, 3 months, and 1 year for male and
female donors and nondonors. For all questions, the
percentages of responses at each time point are simi-
lar for donors and nondonors, as suggested by the
overlapping CIs.
Males were less likely to report poorer sexual func-
tioning than females for all questions at all time
points except in the area of sexual satisfaction. The
percentage feeling poorer sexual desire was higher at
3 months versus the evaluation for both males and
females but dropped at 1 year for both. This phenom-
enon was not as evident for the other 3 questions.
What Variables Predict Poorer Sexual Function
at Evaluation?
Table 4 shows results for the 4 sexual function ques-
tions at evaluation. There were no significant differen-
ces between donors and nondonors in any of the 4
areas of sexual functioning. Females were signifi-
cantly more likely than males to report problems with
sexual desire and difficulty achieving orgasm,
whereas males were more likely to be dissatisfied with
their overall sex life. Unmarried respondents had a
higher probability of having problems with getting an
erection or reaching orgasm and of being dissatisfied
with their sex life. Respondents whose intended recip-
ient was their spouse had a significantly higher prob-
ability of being dissatisfied with their sex life. Race
was significant only in predicting erection in males,
with nonwhites having greater odds of lower erectile
function.
What Is the Association Between Poorer Sexual
Functioning After Donation and Donation-
Specific Factors?
Table 4 shows models for the 3-month and 1-year
postdonation time points. We examined correlates,
including recovery time, complications, pain, physical
symptoms, view of physical appearance, and worries
about health. At 3 months, concerns about appear-
ance, abdominal pain, and not feeling back to normal
were associated with reporting poorer sexual function-
ing. Donors who felt that their appearance was worse
or much worse were significantly more likely to report
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lower sexual desire (OR, 4.14; 95% CI, 1.02-16.79),
and donors whose abdominal pain interfered with
their daily life were more likely to report difficulty
reaching orgasm (OR, 3.98; 95% CI, 1.30-12.16).
Donors who did not feel back to normal at 3 months
were more likely to report dissatisfaction with their
sexual life (OR, 3.58; 95% CI, 1.43-8.99).
At 1 year, no donation-specific variables were signif-
icantly associated with sexual functioning, although
the effect of not feeling back to normal was attenuated
from the effect seen at 3 months (OR, 2.80; 95% CI,
0.94-8.37).
What Are the Probabilities of Poorer Sexual
Functioning at the 3 Time Points and How Do
These Differ Before and After Donation?
We tested for differences in the probability of poorer
sexual functioning over time and adjusted for sex
TABLE 3. Postdonation Characteristics of Living Liver Donors
Month 3, n5105, %(n) Year 1, n5107, %(n)
Medical variables
Left lobe donor 8% (8) 7% (7)
Number of hospitalizations*
0 87% (91) 87% (93)
1 10% (11) 7% (8)
2 3% (3) 6% (6)
1 Complication* 28% (29) 36% (39)
1 Complication Clavien grade 2* 18% (19) 21% (22)
Postdonation pain medication use† 10% (11) 12% (13)
Recipient died 3% (3) 5% (5)
Recipient retransplanted 4% (4) 5% (5)
Self-reported variables‡
Consistently depressed or down 5% (5) 3% (3)
Missing 14% (15) 22% (24)
Much less interested/able to enjoy things 9% (9) 4% (4)
Missing 16% (17) 24% (26)
General or overall appearance is worse/much worse§ 12% (13) 7% (8)
Self-reported medical problems§ 21% (22) 16% (17)
Abdominal pain interferes with daily life§ 56% (59) 46% (49)
At least mild abdominal pain on the day of survey§ 40% (42) 24% (26)
Bowel symptoms interfere with daily life§ 37% (39) 40% (43)
Feels completely recovered§ 41% (43) 72% (77)
Recovered slower/much slower than expected§ 24% (25) 18% (19)
Percent recovery§
0%-20% 1% (1) 1% (1)
41%-60% 4% (4) 0% (0)
61%-80% 18% (19) 6% (6)
80%-99% 32% (34) 19% (20)
100% 41% (43) 72% (77)
Feels back to normal 53% (56) 75% (80)
Missing 5% (5) 9% (10)
Worries sometimes or often about physical effects of donation 42% (44) 23% (25)
Missing 6% (6) 20% (21)
At least a little worried about own health 35% (37) 21% (22)
Missing 6% (6) 19% (20)
Worries donation will have negative effects on health in the future 27% (28) 16% (17)
Missing 6% (6) 21% (22)
Worries will never feel 100% well 14% (15) 7% (7)
Missing 6% (6) 21% (22)
NOTE: Sixty-one donors had information available at month 3 only, 63 had information available at 1 only, and 44 had
information available at both. Donors who only had month 3 data differed significantly from those who had only year 1
data in terms of age (40.1 versus 35.2 years), smoking history (36% versus 14%), and marital status (41% versus 24%
married).
*Cumulative number up to that time point. There were no Clavien complications higher than grade 2 in the first year after
donation.
†As reported at that time point on case report forms.
‡See Table 1 for specific questions asked for self-reported variables.
§Missing5%.
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(Table 5). For all 4 questions, no significant differences
existed between the probabilities of poor sexual func-
tioning at 3 months versus the evaluation. The proba-
bility of poor sexual desire decreased at 1 year with
respect to the evaluation (P<0.001) and 3 months
(P50.001). This trend was seen in the other 3 ques-
tions but did not reach significance. Females had a
higher probability of poorer sexual function than
males, but this difference was significant only in the
areas of sexual desire and reaching orgasm (Table 5).
Does Sexual Functioning at Evaluation Predict
Sexual Functioning in the First Year After
Donation?
Poorer sexual functioning at evaluation was strongly
associated with a higher probability of poorer sexual
functioning in the first year after donation in the
areas of sexual desire (OR, 5.69; 95% CI, 1.46-22.21)
and satisfaction with sex life (OR, 5.12; 95% CI, 1.56-
16.77), with adjustments for sex and time.
Sensitivity Analysis
As a sensitivity analysis, participants who reported no
sexual activity for erectile and orgasmic function were
excluded from the 3 sets of models in Table 4 (n531
nondonors, n541 donors). The results were largely
unchanged, with some previously marginally signifi-
cant variables becoming nonsignificant, likely because
of the reduction in sample size. More importantly, the
magnitude and direction of the effects remained the
same. Most respondents who completed surveys at
more than 1 time point did not consistently report
having no sexual activity on all of their surveys. Addi-
tional testing showed that those included in the longi-
tudinal models did not have significantly different
sexual functioning than those who responded at only
1 time point.
DISCUSSION
Living donors differ from other surgical patients
because they undergo their procedure without any
Figure 2. Percentage of subjects showing difficulty in sexual functioning, which was defined as responding half the time or less on
desire, erection, and orgasm questions and neutral, dissatisfied, or very dissatisfied on the sexual satisfaction question. SE bars were
calculated with the normal approximation to the binomial distribution.
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TABLE 4. Correlates of Sexual Functioning at Evaluation, 3 Months, and 1 Year
Evaluation (n5256, 122
Donors, 134 Nondonors)
3 Months After Donation,
(n5105, All Donors)
1 Year After Donation,
(n5107, All Donors)
OR (95% CI) P Value OR (95% CI) P Value OR (95% CI) P Value
Probability of feeling sexual
desire half the time or less
Donor
(reference5nondonor)
1.20 (0.71-2.01) 0.50 — — — —
Female (reference5male) 3.15 (1.85-5.35) <0.001 2.95 (1.19-7.30) 0.02 3.16 (1.24-8.08) 0.02
Marital status (referen-
ce5married not donating to
spouse)
Unmarried 1.02 (0.60-1.74) 0.93 1.14 (0.45-2.91) 0.78 1.69 (0.55-5.24) 0.36
Married donating to
spouse
2.82 (0.74-10.72) 0.13 0.68 (0.10-4.73) 0.70 0.57 (0.05-6.49) 0.65
Age (per 10 years) — — 1.90 (1.17-3.09) 0.01 — —
Compared to before
donation, my appearance is
worse or much worse versus
the same, better or much
better*
— — 4.14 (1.02-16.79) 0.047 — —
Probability of getting an
erection half the time or
less (males only)†
Donor
(reference5nondonor)
0.70 (0.19-2.62) 0.60 — — — —
Nonwhite versus white 8.47 (1.56-45.94) 0.01 — — — —
Unmarried versus married‡ 7.14 (1.66-30.77) 0.008 0.73 (0.12-4.58) 0.74 1.67 (0.17-16.02) 0.66
Probability of having an
orgasm half the time or
less
Donor
(reference5nondonor)
0.86 (0.45-1.66) 0.65 . .
Female (reference5male) 10.19 (4.10-25.36) <0.001 1.69 (0.61-4.72) 0.31 0.96 (0.37-2.50) 0.94
Marital status (referen-
ce5married not donating to
spouse)
Unmarried 2.21 (1.07-4.55) 0.03 0.88 (0.31-2.52) 0.81 1.25 (0.40-3.86) 0.70
Married donating to
spouse
2.63 (0.80-8.67) 0.11 0.38 (0.05-3.02) 0.40 0.92 (0.08-10.60) 0.94
Age (per 10 years) 1.40 (0.98-1.99) 0.06 2.45 (1.40-4.30) 0.002 — —
Abdominal pain interferes
with my daily life‡
— — 3.98 (1.30-12.16) 0.02 — —
Probability of being neutral,
dissatisfied, or very dissatis-
fied with overall sex life
Donor
(reference5nondonor)
0.93 (0.54-1.61) 0.80 — — — —
Female (reference5male) 0.34 (0.19-0.61) <0.001 1.41 (0.57-3.50) 0.46 0.78 (0.33-1.89) 0.59
Age (per 10 years) 1.55 (1.15-2.10) 0.004 — — — —
Marital status (referen-
ce5married not donating to
spouse)
Unmarried 2.78 (1.51-5.12) 0.001 2.09 (0.77-5.68) 0.15 1.75 (0.58-5.31) 0.32
Married donating to
spouse
5.95 (1.59-22.18) 0.008 6.17 (0.76-50.33) 0.09 3.84 (0.54-27.17) 0.18
Current or previous smoker
(reference5never smoked)
— — 4.42 (1.54-12.68) 0.006 — —
Does not feel back to
normal§
— — 3.58 (1.43-8.99) 0.007 2.80 (0.94-8.37) 0.07
NOTE: Separate logistic regression models were used for each time point. Data are for all donors and nondonors at evalua-
tion and for donors at 3 months and 1 year after donation.
*Missing for n51, excluded from model.
†n5114 males at evaluation (48 donors, 66 nondonors), n547 male donors at 3 months, n546 male donors at 1 year.
The parameter of married donating to spouse could not be estimated because only 1 male donated to his spouse at the
evaluation, 3 donated at 3 months, and 0 donated at 1 year.
‡Missing for n52, excluded from model.
§Missing for n55 at 3 months and n510 at 1 year, excluded from models.
expectation of health benefit. Although an extensive
literature exists on sexual functioning recovery after
types of abdominal/genitourinary surgery known to
affect sexual functioning (eg, prostate, urological, hys-
terectomy, and colostomy), this literature is less rele-
vant for living liver donors, who go into the procedure
in good health. The present data provide a more com-
prehensive understanding of the sexual issues of liv-
ing liver donors than previously available. We asked
participants questions on key domains of sexual func-
tioning important to patients. These data can provide
a useful basis for developing future psychoeduca-
tional interventions to prepare donors for the postop-
erative recovery period.
Overall, donors were most likely to report poorer sex-
ual functioning at the evaluation phase and at 3
months after donation, but they were least likely to
report problems at 1 year. Donors who had poorer sex-
ual functioning at evaluation continued to have poorer
function in the early 3-month recovery period but were
less likely to have these issues by 1 year. Although
donors typically report high levels of physical and emo-
tional functioning before donation (in fact, they are
selected for these features), the fact that both donors
and nondonors reported poorer sexual functioning at
the evaluation phase demonstrates that some areas of
psychosocial functioning are not optimal and might be
affected by the stresses inherent in the decision to
donate and the evaluation process. Prior studies of
donor stress and anxiety show the predonation period
to be the most stressful for donors, with a reduction in
distress within the early months after donation.1,3
Differences at evaluation did not persist after dona-
tion, except that females were consistently more likely
to report poorer levels of sexual desire. Because there
are no inherent differences between males and
females in the level of sexual functioning,9,10 this sug-
gests that possible issues related to the donation
experience are contributing to these results. That
both sexes experienced difficulties at evaluation ver-
sus the other time points suggests that this stressful
time period affects both sexes but perhaps somewhat
differently. A prior investigation of sex differences
determined that at the predonation phase, women
were more likely to be concerned about the donation’s
impact on their family and social obligations.24
Although we did not ask about specific stresses
reflecting women’s various roles in their families with
respect to caregiving responsibilities, such issues may
continue after donation and affect sexual desire.
Those with donation-related complaints (abdominal
pain, concerns about appearance, and not feeling back
to normal again) reported lower levels in several areas
of sexual functioning. Consistent with the existing liver
donor literature that shows decrements in physical
functioning in the immediate postoperative period (typ-
ically the first 3 months) with recovery to baseline lev-
els within 1 year,1 donors may expect that until they
are feeling physically better and back to normal,
aspects of normalcy such as sexual functioning may be
decreased. Although we hypothesized that donor con-
cerns about their recovery and the impact of donation
on their current and future health would be associated
with poorer sexual functioning, this was not the case.
Limitations
Missing surveys in the data set and especially the
lack of longitudinal data for the nondonors are a limi-
tation. However, we were able to use analytic
TABLE 5. Predicted Probabilities of Poor Sexual Functioning by Sex and Time Point
Time Point
Female,
Mean (SE)
Male,
Mean (SE)
P Value,
Males Versus
Females
P Value,
Versus
Evaluation
P Value
Versus
Month 3
Probability of feeling
sexual desire half
the time or less
Evaluation 0.76 (0.06) 0.44 (0.10) 0.003 — —
Month 3 0.69 (0.08) 0.35 (0.10) 0.32 —
Year 1 0.26 (0.09) 0.08 (0.04) <0.001 0.001
Probability of getting
an erection half the
time or less (Males
only)
Evaluation — 0.12 (0.06) — — —
Month 3 — 0.12 (0.07) 0.94 —
Year 1 — 0.07 (0.07) 0.62 0.67
Probability of having
an orgasm half the
time or less
Evaluation 0.40 (0.07) 0.10 (0.05) 0.001 — —
Month 3 0.40 (0.08) 0.10 (0.05) 0.98 —
Year 1 0.19 (0.08) 0.04 (0.03) 0.06 0.08
Probability of being
neutral, dissatis-
fied, or very dissat-
isfied with overall
sex life
Evaluation 0.41 (0.07) 0.40 (0.09) 0.93 — —
Month 3 0.44 (0.09) 0.43 (0.10) 0.74 —
Year 1 0.29 (0.08) 0.28 (0.10) 0.23 0.17
NOTE: Among the subset of 82 donors (52 females and 30 males) with surveys at the evaluation and at least 1 of the 3-
month and 1-year time points.
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techniques to make the best use of all available data.
We did not have data on donors and nondonors who
did not enroll in A2ALL. Additionally, A2ALL had
fewer minorities represented in comparison with all
donors during that era, and this may also have intro-
duced a bias. It is important to note that the baseline
sexual functioning of donors before they entered the
donation evaluation process is unknown. Donor con-
cerns over the evaluation process, their own future
health and well-being, and the health and well-being
of the intended recipients may have affected their
responses. It is, therefore, possible that donor base-
line sexual functioning was higher than that at evalu-
ation, and this might explain the improvement of
sexual functioning after 1 year above the scores at
evaluation. Although comprehensive sexual function-
ing instruments exist, in an effort not to overburden
respondents, a smaller set of sexual functioning items
was chosen. However, the questions asked capture key
domains representing sexual functioning. Similarly,
data on the specifics of how postdonation factors, such
as aspects of physical appearance, may have influ-
enced the donors’ sexual functioning were not
obtained. We did not have data on antihypertensive or
antidepressant medication usage, but these medical
issues were uncommon in our cohort and unlikely to
affect the findings. It is possible that some participants
experienced embarrassment or discomfort when they
were responding to sexual functioning questions, and
this may have altered their answers or willingness to
respond at all. In addition, the questions do not specify
whether they refer to sexual functioning with a consist-
ent partner or other patterns of sexual activity. How-
ever, these items have been used widely in both
interviewer-driven and self-reporting formats.
In conclusion, sexual function questions are likely
not a routine part of donor surgical follow-up.
Although patients might wish to speak with their
physicians/clinicians about their sexual functioning
concerns, these conversations are infrequently initi-
ated by the patient, and clinicians must be sensitive
to the need to ask. Additionally, the focus of a typical
postdonation follow-up examination may be on known
or expected complications, with less consideration of
the broader impact of the surgery on a range of func-
tions such as sexual activity. Thus, close monitoring
during early recovery with inquiries into sexual func-
tioning issues will provide donors an opportunity to
report any problems and allow them to discuss con-
cerns. Awareness that the inherent stresses in the
predonation phase may have effects on sexual func-
tioning is important. Educating donors on what to
expect with sexual functioning, specifically early in
recovery, will probably not lessen these problems but
will allow donors to understand and prepare for this
phase of their recovery. Donor teams might consider
interventions to minimize scarring, prevent hernias,
and prepare for postdonation physical appearance to
decrease the impact of concerns over appearance on
sexual desire. Efforts to educate the donors’ sexual
partners may also help to relieve/reduce anxieties
and normalize expectations. As we work to maximize
the positive psychological and physical experiences
associated with living donation, efforts toward reduc-
ing stress by educating donors on what is expected
and normal and what are anticipated outcomes are
the goals of all donor teams. Appreciating that sexual
functioning is an essential aspect of donor quality of
life directs our focus toward this important area.
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